Creative Planning

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
3,934
Total Value
104536811896
Accession Number
0001540235-25-000003
Form Type
13F-HR
CIK
0001540235
Manager Name
Creative Planning
Data Enrichment
78% identified
3,087 identified847 unidentified

Holdings

3,934 positions
Manager:
SEC
Search and click to pin securities to the top
Page 163 of 172
New Gold Inc. /FI
NGD|644535106
Shares:
25504(+22.0%)
Value:
$94.6M(+82.5%)
BrightSpire Capital, Inc.
BRSP|10949T109
Shares:
17011(-13.6%)
Value:
$94.6M(-14.8%)
Verve Therapeutics, Inc.
VERV|92539P101
Shares:
20296(-7.9%)
Value:
$92.8M(-25.4%)
WILLAMETTE VALLEY VINEYARDS INC
WVVI|969136100
Shares:
15600(+0.0%)
Value:
$92.7M(+77.3%)
APARTMENT INVESTMENT & MANAGEMENT CO
AIV|03748R747
Shares:
10450
Value:
$92.0M
abrdn Total Dynamic Dividend Fund
AOD|00326L100
Shares:
10828(-2.3%)
Value:
$90.8M(-2.5%)
PIMCO STRATEGIC INCOME FUND, INC.
RCS|72200X104
Shares:
14253(+31.4%)
Value:
$89.1M(+7.8%)
DoorDash, Inc.
DASH|25809K105
Shares:
23300(-23.0%)
Value:
$88.5M(+9.9%)
Latham Group, Inc.
SWIM|51819L107
Shares:
13703(+18.7%)
Value:
$88.1M(+9.7%)
Nuveen Preferred & Income Opportunities Fund
JPC|67073B106
Shares:
10975(-52.5%)
Value:
$87.4M(-51.9%)
AerSale Corp
ASLE|00810F106
Shares:
11640(+4574.7%)
Value:
$87.2M(+5456.7%)
Wave Life Sciences Ltd.
WVE|Y95308105
Shares:
10623
Value:
$85.8M
Perspective Therapeutics, Inc.
CATX|46489V302
Shares:
40230(-0.1%)
Value:
$85.7M(-33.3%)
AbCellera Biologics Inc.
ABCL|00288U106
Shares:
38347(-46.3%)
Value:
$85.5M(-59.1%)
Protalix BioTherapeutics, Inc.
PLX|74365A309
Shares:
32740
Value:
$83.8M
Stoke Therapeutics, Inc.
STOK|86150R107
Shares:
12598
Value:
$83.8M
Opendoor Technologies Inc.
OPEN|683712103
Shares:
82008(+11.2%)
Value:
$83.6M(-29.1%)
IAMGOLD CORP
IAG|450913108
Shares:
13311(+20.8%)
Value:
$83.2M(+46.3%)
Organogenesis Holdings Inc.
ORGO|68621F102
Shares:
19187(+6.4%)
Value:
$82.9M(+43.6%)
09260Q108
09260Q108
Shares:
13132(-5.0%)
Value:
$82.2M(-20.1%)